SUPPORTIVE CARE FOR PEOPLE LIVING WITH OR BEYOND CANCER TREATMENT
Dr Hannah Wardill, Hospital Research Foundation Fellow, University of Adelaide & Head of Supportive Oncology Group (Precision Cancer Medicine)
SAHMRI (South Australian Health and Medical Research Institute)
RESEARCHER PROFILE
Filmed in Adelaide, South Australia | January 2025
Dr Hannah Wardill is a Hospital Research Foundation Fellow and lead of the Supportive Oncology Research Group (SORG), in the School of Biomedicine, University of Adelaide and Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI). She is an Executive Board Member of the Multinational Association for Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO) and Chair of both MASCC/ISOO Patient Partnership Committee & the Palliative Care Clinical Studies Collaborative (PaCCSC) Cancer Symptom Trials (Gut Dysfunction Node; supported by Cancer Australia).
While her research started in understanding how chemotherapy damages gut health, Dr Wardill’s research program has now expanded to include a range of symptoms and side effects including neuropathy, cognitive impairment, infection and malnutrition.
A fierce advocate for supportive cancer care, Dr Wardill is working to improve the visibility of this research area and remind people that optimal cancer control can (and should) involve high quality, evidence-based supportive care to ensure people living with or beyond cancer can live happy and fulfilling lives.
You Might also like
-
Joanne Chio
ICON CANCER CENTRE – SINGAPORE
SINGAPORE -
Precision and personalised nutrition
Laureate Professor Clare Collins is helping people access effective medical nutrition therapies that significantly reduce their risk of chronic disease. She and her team are developing innovative technologies, including apps and online programmes.
-
Respiratory health and the microbiome in the lung environment
Dr Taylor leads the Respiratory Health Group within the Microbiome and Host Health Program. His research employs tailored techniques that allow the lung environment to be characterised to a high level of accuracy, including detailed measurements of airway microbiology (microbiome), mucus composition, and inflammation. This information is used to identify predictive markers of chronic lung disease severity as well as determine effective forms of therapy.